Harnessing the power of predatory bacteria as a 'living antibiotic'

November 23, 2016

A naturally occurring predatory bacterium is able to work with the immune system to clear multi-drug resistant Shigella infections in zebrafish, according to a study published today in Current Biology.

It is the first time the predatory bacterium Bdellovibrio bacteriovorus has been successfully used as an injected anti-bacterial therapy and represents an important step in the fight against drug-resistant infections, or 'superbugs'.

Shigella infection is responsible for over 160 million illnesses and over 1 million deaths every year - and is a common cause of 'travellers' diarrhoea.' Cases of drug-resistant Shigella are also on the rise as, although the diarrhoea usually clears up without treatment, antibiotics are often used even in mild cases to stop the diarrhoea faster. Resistance to antibiotics has prompted a team of researchers from Imperial College London and Nottingham University to look to the natural environment for creative solutions to this problem.

To investigate Bdellovibrio's ability to control drug resistant Gram-negative infections, researchers injected zebrafish larvae with a lethal dose of Shigella flexneri strain M90T, resistant to both streptomycin and carbenicillin antibiotics. Bdellovibrio was then injected into the larvae's infection site, and a decrease in the number of Shigella was seen. In the absence of Bdellovibrio, zebrafish were unable to control the replication of Shigella and levels of the bacteria rose.

Wellcome Research Career Development Fellow Dr Serge Mostowy, co-lead author from Imperial College London said: "This study really shows what a unique and interesting bacterium Bdellovibrio is as it presents this amazing natural synergy with the and persists just long enough to kill prey bacteria before being naturally cleared. It's an important milestone in research into the use of a living antibiotic that could be used in animals and humans."

Bdellovibrio can invade and kill a range of Gram-negative bacteria, such as E. coli and Salmonella, in the natural environment. Previous research has shown that it can reduce pathogen numbers in the stomach of chickens when taken as an oral therapy, but there is growing need to develop therapies to target infections in wounds and organs. Successful use of Bdellovibrio highlights its potential uses in tackling a range of drug-resistant Gram-negative bacterial infections that can develop in hospital patients.

Professor Liz Sockett, co-lead author from The University of Nottingham said: "This has been a truly ground-breaking collaboration that shows therapeutic Bdellovibrio in action inside the translucent living zebrafish. The predatory action of the Bdellovibrio breaks the Shigella-pathogen cells and this stimulates the white blood cells; redoubling their 'efforts' against the pathogen and leading to increased survival of the zebrafish 'patients'."

Remarkably, Bdellovibrio is also able to reduce pathogen load in immunocompromised zebrafish larvae that have been depleted of . However, survival is significantly greater in immune-competent zebrafish, showing that Bdellovibrio's maximum therapeutic benefit comes from its ability to work cooperatively with the host's own immune system.

Dr Michael Chew, Science Portfolio Advisor at Wellcome said: "It may be unusual to use a bacterium to get rid of another, but in the light of the looming threat from the potential of beneficial bacteria-animal interactions should not be overlooked. We are increasingly relying on last line antibiotics, and this innovative study demonstrates how predatory bacteria could be an important additional tool to drugs in the fight against resistance."

Explore further: Predatory bacteria offer potential solution to drug resistance problem

More information: 'Injections of predatory bacteria work alongside host immune cells to treat Shigella infections in zebrafish larvae' Current Biology, DOI: 10.1016/j.cub.2016.09.067

Related Stories

Living antibiotic effective against Salmonella

June 27, 2011

Scientists have tested a predatory bacterium – Bdellovibrio – against Salmonella in the guts of live chickens. They found that it significantly reduced the numbers of Salmonella bacteria and, importantly, showed ...

E. coli survives predatory bacteria by playing hide and seek

February 22, 2016

The majority of disease-causing bacteria in the body are rendered harmless by the protective effects of the immune system. Those that manage to escape the immune system can be killed by antibiotics, but bacteria are becoming ...

Recommended for you

Finding a lethal parasite's vulnerabilities

December 15, 2017

An estimated 100 million people around the world are infected with Strongyloides stercoralis, a parasitic nematode, yet it's likely that many don't know it. The infection can persist for years, usually only causing mild symptoms. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.